Evidence map›Paper›PMID 36077641›Full record

ArticleCancers2022

Online Crowdfunding for Urologic Cancer Care.

Pawel Rajwa, Philip Hopen, Jakub Wojnarowicz, Julia Kaletka, Iga Paszkiewicz, Olga Lach-Wojnarowicz, Hadi Mostafaei, Wojciech Krajewski, David D'Andrea, Bartosz Małkiewicz and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. GoFundMe®: Crowdfunding Among Young Adult Patients With Cancer.Clinical journal of oncology nursing · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 8 countries.

Pawel RajwaDepartment of Urology, Medical University of Vienna, 1090 Vienna, Austria.
Philip HopenData Science & Clinical Analytics, New Century Health, Boston, MA 02481, USA.
Jakub WojnarowiczDepartment of Urology, Medical University of Silesia, 41-800 Zabrze, Poland.
Julia KaletkaDepartment of Urology, Medical University of Silesia, 41-800 Zabrze, Poland.
Iga PaszkiewiczDepartment of Urology, Medical University of Silesia, 41-800 Zabrze, Poland.ORCID 0000-0002-0206-7044
Olga Lach-WojnarowiczDepartment of Urology, Medical University of Silesia, 41-800 Zabrze, Poland.
Hadi MostafaeiDepartment of Urology, Medical University of Vienna, 1090 Vienna, Austria.
Wojciech KrajewskiDepartment of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, 50-556 Wroclaw, Poland.
David D'AndreaDepartment of Urology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-1625-1077
Bartosz MałkiewiczDepartment of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, 50-556 Wroclaw, Poland.ORCID 0000-0002-5933-3753
Andrzej ParadyszDepartment of Urology, Medical University of Silesia, 41-800 Zabrze, Poland.
Guillaume PloussardDepartment of Urology, La Croix du Sud Hospital, 31130 Quint Fonsegrives, France.
Marco MoschiniDivision of Oncology, Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Benjamin N BreyerDepartment of Urology, University of California San Francisco, San Francisco, CA 94143, USA.
Benjamin PradereDepartment of Urology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-7768-8558
Shahrokh F ShariatDepartment of Urology, Medical University of Vienna, 1090 Vienna, Austria.
Michael S LeapmanDepartment of Urology, Yale University School of Medicine, New Haven, CT 06520, USA.
Medical University of Silesia · PLLyon Genou Centre Albert Trillat · FRMedical University of Vienna · ATWroclaw Medical University · PLAl-Ahliyya Amman University · JOCentury Health · USIRCCS Ospedale San Raffaele · ITUniversity of California, San Francisco · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Background: we aimed to characterize the financial needs expressed through online crowdfunding for urologic cancers. Methods: the data used in this study came from the online crowdfunding platform GoFundMe.com. Using an automated software method, we extracted data for campaigns related to urologic cancers. Subsequently, four independent investigators reviewed all extracted data on prostate, bladder, kidney and testicular cancer. We analyzed campaigns’ basic characteristics, goals, fundraising, type of treatment and factors associated with successful campaigns. Results: in total, we identified 2126 individual campaigns, which were related to direct treatment costs (34%), living expenses (17%) or both (48%). Median fundraising amounts were greatest for testicular cancer. Campaigns for both complementary and alternative medicine (CAM) (median $11,000) or CAM alone (median $8527) achieved higher fundraising totals compared with those for conventional treatments alone (median $5362) (p < 0.01). The number of social media shares was independently associated with campaign success and highest quartile of fundraising. Conclusions: using an automated web-based approach, we identified and characterized online crowdfunding for urologic cancer care. These findings indicated a diverse range of patient needs related to urologic care and factors related to campaigns’ success.

Indexed as

bladder cancercrowdfundingkidney cancerprostate cancertesticular cancerurology

Identifiers

PMID36077641
PMCPMC9454944
OpenAlexW4293104204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.